Cargando…
Structures of HIV-1-Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
Broadly neutralizing antibodies (bNAbs) against HIV-1-Env V1V2 arise in multiple donors. However, atomic-level interactions had only been determined with antibodies from a single donor, making commonalities in recognition uncertain. Here we report the co-crystal structure of V1V2 with antibody CH03...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833398/ https://www.ncbi.nlm.nih.gov/pubmed/26689967 http://dx.doi.org/10.1038/nsmb.3144 |
_version_ | 1782427354013892608 |
---|---|
author | Gorman, Jason Soto, Cinque Yang, Max M. Davenport, Thaddeus M. Guttman, Miklos Bailer, Robert T. Chambers, Michael Chuang, Gwo-Yu DeKosky, Brandon J. Doria-Rose, Nicole A. Druz, Aliaksandr Ernandes, Michael J. Georgiev, Ivelin S. Jarosinski, Marissa C. Joyce, M. Gordon Lemmin, Thomas M. Leung, Sherman Louder, Mark K. McDaniel, Jonathan R. Narpala, Sandeep Pancera, Marie Stuckey, Jonathan Wu, Xueling Yang, Yongping Zhang, Baoshan Zhou, Tongqing Mullikin, James C. Baxa, Ulrich Georgiou, George McDermott, Adrian B. Bonsignori, Mattia Haynes, Barton F. Moore, Penny L. Morris, Lynn Lee, Kelly K. Shapiro, Lawrence Mascola, John R. Kwong, Peter D. |
author_facet | Gorman, Jason Soto, Cinque Yang, Max M. Davenport, Thaddeus M. Guttman, Miklos Bailer, Robert T. Chambers, Michael Chuang, Gwo-Yu DeKosky, Brandon J. Doria-Rose, Nicole A. Druz, Aliaksandr Ernandes, Michael J. Georgiev, Ivelin S. Jarosinski, Marissa C. Joyce, M. Gordon Lemmin, Thomas M. Leung, Sherman Louder, Mark K. McDaniel, Jonathan R. Narpala, Sandeep Pancera, Marie Stuckey, Jonathan Wu, Xueling Yang, Yongping Zhang, Baoshan Zhou, Tongqing Mullikin, James C. Baxa, Ulrich Georgiou, George McDermott, Adrian B. Bonsignori, Mattia Haynes, Barton F. Moore, Penny L. Morris, Lynn Lee, Kelly K. Shapiro, Lawrence Mascola, John R. Kwong, Peter D. |
author_sort | Gorman, Jason |
collection | PubMed |
description | Broadly neutralizing antibodies (bNAbs) against HIV-1-Env V1V2 arise in multiple donors. However, atomic-level interactions had only been determined with antibodies from a single donor, making commonalities in recognition uncertain. Here we report the co-crystal structure of V1V2 with antibody CH03 from a second donor and model Env interactions of antibody CAP256-VRC26 from a third. These V1V2-directed bNAbs utilized strand-strand interactions between a protruding antibody loop and a V1V2 strand, but differed in their N-glycan recognition. Ontogeny analysis indicated protruding loops to develop early, with glycan interactions maturing over time. Altogether, the multidonor information suggested V1V2-directed bNAbs to form an ‘extended class’, for which we engineered ontogeny-specific antigens: Env trimers with chimeric V1V2s that interacted with inferred ancestor and intermediate antibodies. The ontogeny-based design of vaccine antigens described here may provide a general means for eliciting antibodies of a desired class. |
format | Online Article Text |
id | pubmed-4833398 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
record_format | MEDLINE/PubMed |
spelling | pubmed-48333982016-06-21 Structures of HIV-1-Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design Gorman, Jason Soto, Cinque Yang, Max M. Davenport, Thaddeus M. Guttman, Miklos Bailer, Robert T. Chambers, Michael Chuang, Gwo-Yu DeKosky, Brandon J. Doria-Rose, Nicole A. Druz, Aliaksandr Ernandes, Michael J. Georgiev, Ivelin S. Jarosinski, Marissa C. Joyce, M. Gordon Lemmin, Thomas M. Leung, Sherman Louder, Mark K. McDaniel, Jonathan R. Narpala, Sandeep Pancera, Marie Stuckey, Jonathan Wu, Xueling Yang, Yongping Zhang, Baoshan Zhou, Tongqing Mullikin, James C. Baxa, Ulrich Georgiou, George McDermott, Adrian B. Bonsignori, Mattia Haynes, Barton F. Moore, Penny L. Morris, Lynn Lee, Kelly K. Shapiro, Lawrence Mascola, John R. Kwong, Peter D. Nat Struct Mol Biol Article Broadly neutralizing antibodies (bNAbs) against HIV-1-Env V1V2 arise in multiple donors. However, atomic-level interactions had only been determined with antibodies from a single donor, making commonalities in recognition uncertain. Here we report the co-crystal structure of V1V2 with antibody CH03 from a second donor and model Env interactions of antibody CAP256-VRC26 from a third. These V1V2-directed bNAbs utilized strand-strand interactions between a protruding antibody loop and a V1V2 strand, but differed in their N-glycan recognition. Ontogeny analysis indicated protruding loops to develop early, with glycan interactions maturing over time. Altogether, the multidonor information suggested V1V2-directed bNAbs to form an ‘extended class’, for which we engineered ontogeny-specific antigens: Env trimers with chimeric V1V2s that interacted with inferred ancestor and intermediate antibodies. The ontogeny-based design of vaccine antigens described here may provide a general means for eliciting antibodies of a desired class. 2015-12-21 2016-01 /pmc/articles/PMC4833398/ /pubmed/26689967 http://dx.doi.org/10.1038/nsmb.3144 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Gorman, Jason Soto, Cinque Yang, Max M. Davenport, Thaddeus M. Guttman, Miklos Bailer, Robert T. Chambers, Michael Chuang, Gwo-Yu DeKosky, Brandon J. Doria-Rose, Nicole A. Druz, Aliaksandr Ernandes, Michael J. Georgiev, Ivelin S. Jarosinski, Marissa C. Joyce, M. Gordon Lemmin, Thomas M. Leung, Sherman Louder, Mark K. McDaniel, Jonathan R. Narpala, Sandeep Pancera, Marie Stuckey, Jonathan Wu, Xueling Yang, Yongping Zhang, Baoshan Zhou, Tongqing Mullikin, James C. Baxa, Ulrich Georgiou, George McDermott, Adrian B. Bonsignori, Mattia Haynes, Barton F. Moore, Penny L. Morris, Lynn Lee, Kelly K. Shapiro, Lawrence Mascola, John R. Kwong, Peter D. Structures of HIV-1-Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design |
title | Structures of HIV-1-Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design |
title_full | Structures of HIV-1-Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design |
title_fullStr | Structures of HIV-1-Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design |
title_full_unstemmed | Structures of HIV-1-Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design |
title_short | Structures of HIV-1-Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design |
title_sort | structures of hiv-1-env v1v2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833398/ https://www.ncbi.nlm.nih.gov/pubmed/26689967 http://dx.doi.org/10.1038/nsmb.3144 |
work_keys_str_mv | AT gormanjason structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT sotocinque structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT yangmaxm structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT davenportthaddeusm structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT guttmanmiklos structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT bailerrobertt structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT chambersmichael structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT chuanggwoyu structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT dekoskybrandonj structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT doriarosenicolea structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT druzaliaksandr structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT ernandesmichaelj structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT georgievivelins structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT jarosinskimarissac structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT joycemgordon structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT lemminthomasm structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT leungsherman structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT loudermarkk structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT mcdanieljonathanr structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT narpalasandeep structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT panceramarie structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT stuckeyjonathan structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT wuxueling structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT yangyongping structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT zhangbaoshan structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT zhoutongqing structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT mullikinjamesc structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT baxaulrich structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT georgiougeorge structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT mcdermottadrianb structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT bonsignorimattia structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT haynesbartonf structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT moorepennyl structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT morrislynn structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT leekellyk structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT shapirolawrence structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT mascolajohnr structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign AT kwongpeterd structuresofhiv1envv1v2withbroadlyneutralizingantibodiesrevealcommonalitiesthatenablevaccinedesign |